CCSA investing $1.8 million in non-therapeutic cannabis use research Where do 'magic mushrooms' belong in patient treatment? COVID-19: Quebecers could wait up to 90 days for second dose of vaccine Sexual dysfunction may persist after discontinuing SSRI or SNRI antidepressants Health Canada safety review reports on risk of persistent, worsening or new sexual dysfunction after stopping SSRI or SNRI treatment. Flu facts and myths Canadian pharmacists eager to administer COVID-19 vaccines in early stages of rollout Community pharmacy has role to play to ensure effective rollout of all three phases of the national COVID-19 vaccination strategy. Bold action needed on pandemic sick benefits No unexpected side effects from COVID-19 shots given in Canada so far: Health Canada Usual doses of tramadol may cause visual and auditory hallucinations Health Canada safety review identifies new risk, particularly in people older than age 65. Health Canada delays drug pricing reforms, citing COVID challenges for manufacturers Health Canada says it's delaying the implementation of long-awaited changes to Canada's drug-pricing regime by another six months. First Previous 97 98 99 100 101 Next Last
